#502362
(Poist leithdháilte laistigh de chleachtadh APS/PDB do bhliain n
(Posts pre-allocated within the APS/PDB exercise for year n
Scag na torthaí
Bailiúcháin
29 toradh in 11 doiciméad
#502363
(Poist a iarrfar sa chéad nós imeachta APS/PDB eile (2 AD)
(Posts to be requested in the next APS/PDB procedure (2 AD)
#645720
(Poist leithdháilte laistigh de chleachtadh APS/PDB do bhliain n
(Posts pre-allocated within the APS/PDB exercise for year n
#645721
(Poist a iarrfar sa chéad nós imeachta APS/PDB eile (2 AD)
(Posts to be requested in the next APS/PDB procedure (2 AD)
#1981522
“Fornæs ApS” agus “Smedegaarden A/S”.
‘Fornæs ApS’ and ‘Smedegaarden A/S’.
#2059997
Danaqua Aps (An Danmhairg)
Danaqua Aps (Denmark)
#2154825
Cable 77 Danmark ApS (an Danmhairg),
Cable 77 Danmark ApS (Denmark),
#2157853
Cuideachta: DuPont Nutrition & Biosciences ApS;
Company: DuPont Nutrition & Biosciences ApS;
#2157871
DuPont Nutrition & Biosciences ApS, 2019 (neamhfhoilsithe).
DuPont Nutrition & Biosciences ApS, 2019 (unpublished).
#2157890
Iarratasóir: DuPont Nutrition & Biosciences ApS Langebrogade 1, DK-1001 Cóbanhávan K, an Danmhairg
Applicant: DuPont Nutrition & Biosciences ApS Langebrogade 1, 1001 Copenhagen K, Denmark
#2282138
Cable 77 Danmark ApS (an Danmhairg),
Cable 77 Danmark ApS (Denmark),
#2751105
Rátáil Faireachais um Rialú Ascnaimh — APS, a shainítear i bhFoscríbhinn 6 a ghabhann le hIarscríbhinn I;
Approach Control Surveillance Rating – APS, defined in Appendix 6 to Annex I;
#2157891
Is é DuPont Nutrition & Biosciences ApS amháin atá údaraithe chun an bia núíosach 3-fúcaishiollachtóis a chur ar an margadh laistigh den Aontas le linn na tréimhse cosanta sonraí, ach amháin má fhaigheann iarratasóir ina dhiaidh sin údarú i dtaobh an bhia núíosaigh gan tagairt don fhianaise eolaíoch dhílseánaigh nó do na sonraí eolaíocha atá faoi chosaint i gcomhréir le hAirteagal 26 de Rialachán (AE) 2015/2283 nó le comhaontú ó DuPont Nutrition & Biosciences ApS.
During the period of data protection, the novel food 3-Fucosyllactose is authorised for placing on the market within the Union only by DuPont Nutrition & Biosciences ApS, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DuPont Nutrition & Biosciences ApS.
#502364
(Poist is gá do bhliain n cé nach raibh siad á dtuar i gcleachtadh APS/PDB na bliana a bhí i gceist
(Posts required for year n although not foreseen in the APS/PDB exercise of the year in question
#645722
(Poist is gá do bhliain n cé nach raibh siad á dtuar i gcleachtadh APS/PDB na bliana a bhí i gceist
(Posts required for year n although not foreseen in the APS/PDB exercise of the year in question
#2154698
Bhí éisteachtaí ann leis an ngearánach agus le hallmhaireoir sampláilte amháin (Cable 77 Danmark ApS (‘Cable 77’)).
Hearings took place with the complainant and with one sampled importer (Cable 77 Danmark ApS (‘Cable 77’)).
#2750949
rátáil Faireachais um Rialú Ascnaimh (APS), a thugann le fios go bhfuil an sealbhóir ceadúnais inniúil chun seirbhís rialaithe aerthráchta a sholáthar d’aerárthaí teachta, imeachta nó idirthurais agus trealamh faireachais á úsáid;
the Approach Control Surveillance (APS) rating, indicating that the licence holder is competent to provide an air traffic control service to arriving, departing or transiting aircraft with the use of surveillance equipment;
#2750959
Féadfaidh ceann amháin nó níos mó de na formhuinithe seo a leanas a bheith ar rátáil Faireachais um Rialú Ascnaimh (APS):
The Approach Control Surveillance (APS) rating may bear one or more of the following endorsements:
#2751130
I dteannta phointe (b), leis na cuspóirí feidhmiúlachta don oiliúint rátála i ndáil leis an rátáil Faireachais um Rialú Ascnaimh (APS) áiritheofar an méid seo a leanas i ndáil leis na hiarratasóirí:
In addition to point (b), rating training performance objectives for the Approach Control Surveillance (APS) rating shall ensure that applicants:
#2875412
Sholáthair dhá chuideachta (Cable 77 Danmark Aps agus Connect Com GmbH) an fhaisnéis a iarradh agus thoiligh siad a bheith san áireamh sa sampla.
Two companies (Cable 77 Danmark Aps and Connect Com GmbH) provided the requested information and agreed to be included in the sample.
#2875417
Chuir ceann de na cuideachtaí sin, Cable 77 Danmark Aps (An Danmhairg), allmhaireoir neamhghaolmhar, freagra neamhiomlán isteach ar an gceistneoir.
One of these companies, Cable 77 Danmark Aps (Denmark), an unrelated importer, submitted an incomplete questionnaire reply.
#3242127
Chuir Tosoh in iúl nár chomhoibrigh ceann de na trí mhórúsáideoir, Advanced Power Solutions NV (‘APS’), san imscrúdú.
Tosoh pointed out that one of the three major users, Advanced Power Solutions NV (‘APS’), did not cooperate in the investigation.
#2157830
An 1 Deireadh Fómhair 2019, chuir an chuideachta DuPont Nutrition & Biosciences ApS (“an t-iarratasóir”) iarratas faoi bhráid an Choimisiúin i gcomhréir le hAirteagal 10(1) de Rialachán (AE) 2015/2283 chun 3-fúcaishiollachtóis (3-FL), rud a fhaightear trí choipeadh miocróbach le tréithchineál géinmhodhnaithe de Escherichia coli, mar atá tréithchineál K12 MG1655, a chur ar mhargadh an Aontais mar bhia núíosach.
On 1 October 2019, the company DuPont Nutrition & Biosciences ApS (‘the applicant’) submitted an application to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place 3-Fucosyllactose (3-FL), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 MG1655, on the Union market as a novel food.
#2157858
Na staidéir atá sa chomhad iarratais, staidéir arb ar a mbonn a rinne an tÚdarás an bia núíosach dá dtagraítear in Airteagal 1 a mheas, staidéir ar mhaígh an t-iarratasóir gur staidéir dhílseánaigh iad agus nach bhféadfaí an bia núíosach a údarú dá n-uireasa, ní úsáidfear iad chun tairbhe iarratasóra ina dhiaidh sin go ceann tréimhse 5 bliana ó dháta theacht i bhfeidhm an Rialacháin seo gan comhaontú ó DuPont Nutrition & Biosciences ApS.
The studies contained in the application file on the basis of which the novel food referred to in Article 1 have been assessed by the Authority, claimed by the applicant as proprietary and without which the novel food could not have been authorised, shall not be used for the benefit of a subsequent applicant for a period of 5 years from the date of entry into force of this Regulation without the agreement of DuPont Nutrition & Biosciences ApS.
#2157872
DuPont Nutrition & Biosciences ApS, 2019 (neamhfhoilsithe); J. Pitt et al., 2019 Food and Chemical Toxicology, 134. Pitt et al., 2019 An Bia agus An Tocsaineolaíocht Cheimiceach, 134.]
DuPont Nutrition & Biosciences ApS, 2019 (unpublished); J. Pitt et al., 2019 Food and Chemical Toxicology, 134.
#2358253
Tar éis iarratas a fháil ó DuPont Biosciences ApS, iarratas a cuireadh isteach de bhun Airteagal 13(5) de Rialachán (CE) Uimh. 1924/2006, bhí sé de cheangal ar an Údarás tuairim a thabhairt faoin mbunús eolaíoch atá le maíomh sláinte a bhaineann le Bifidobacterium animalis subsp. lactis Bi-07 (Bi-07) agus leis an méid a dhéanann sé ar mhaithe le díleá lachtóis a mhéadú (Ceist Uimh. EFSA-Q-2020-00024).
Following an application from DuPont Nutrition Biosciences ApS, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on the scientific substantiation of a health claim related Bifidobacterium animalis subsp. lactis Bi-07 (Bi-07) and the contribution to increasing lactose digestion (Question No EFSA-Q-2020-00024).
#2358263
Cuireadh na barúlacha a fuair an Coimisiún ó DuPont Nutrition Biosciences ApS agus Tchibo GmbH, de bhun Airteagal 16(6) de Rialachán (CE) Uimh. 1924/2006, san áireamh agus an Rialachán seo á ghlacadh.
The comments from DuPont Nutrition Biosciences ApS and Tchibo GmbH received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006, have been considered when adopting this Regulation.
#2750878
Beidh pribhléidí an fhormhuinithe rátála Rialú Críochfoirt (TCL) arna n-eisiúint roimh an 4 Lúnasa 2024 mar pháirt de phribhléidí an fhormhuinithe aonaid a bhaineann le rátáil Faireachas um Rialú Ascnaimh (APS) nó Faireachas um Rialú Limistéir (ACS).”;
The privileges of the Terminal Control (TCL) rating endorsement issued before 4 August 2024 shall become part of the privileges of the unit endorsement associated with the Approach Control Surveillance (APS) or the Area Control Surveillance (ACS) rating.’;
#3242128
Luaigh Tosoh ansin Airteagal 7(2b) den bhun-Rialachán, ag sonrú ‘[i]n éagmais comhoibriú, féadfaidh an Coimisiún a chinneadh go bhfuil sé i gcomhréir le leas an Aontais mír 2a den Airteagal seo a chur i bhfeidhm’, agus é á mhaíomh gur cheart don Choimisiún a thuiscint ón neamh-chomhoibriú sin nach mbeadh forchur dleachtanna ar an leibhéal níos airde (corrlach frithdhumpála) in aghaidh a leasa, nó gur cheart go mbeadh anailís déanta, ar a laghad, ar thuarascálacha airgeadais APS atá ar fáil go poiblí ina anailís.
Tosoh then cited Article 7(2b) of the basic Regulation, stipulating that ‘[i]n the absence of cooperation the Commission may conclude that it is in accordance with the Union interest to apply paragraph 2a of this Article’, claiming that the Commission should have inferred from this non-cooperation that imposing duties on the higher (dumping margin) level would not be against its interest, or at least should have analysed APS’ publicly available financial reports in its analysis.